# Study to Evaluate the Dosage and Safety of Two Intramuscular Injections of an Investigational Clade B HIV Vaccine

> **NCT01320176** · PHASE1 · COMPLETED · sponsor: **Institut Pasteur** · enrollment: 36 (actual)

## Conditions studied

- HIV

## Interventions

- **BIOLOGICAL:** Investigational HIV vaccine dose A
- **BIOLOGICAL:** Investigational HIV vaccine dose B

## Key facts

- **NCT ID:** NCT01320176
- **Lead sponsor:** Institut Pasteur
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2012-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01320176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01320176, "Study to Evaluate the Dosage and Safety of Two Intramuscular Injections of an Investigational Clade B HIV Vaccine". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01320176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*